Lixia Zhang

Lixia Zhang has a diverse work experience across various companies and roles. Lixia is currently the Director of Data Science and Biostatistics at Scipher Medicine since February 2022. Previously, they worked as a Principal Data Scientist at Scipher Medicine from October 2019 to January 2022.

Prior to their role at Scipher Medicine, Lixia was a Senior Data Scientist at BERG Health from October 2018 to October 2019. Lixia also worked as a Data Scientist at BERG Health from September 2016 to September 2018.

Lixia has also gained experience at L.E.K. Consulting, where they worked as a Data Analyst from December 2015 to May 2016. During their time at L.E.K. Consulting, they conducted market insight studies and analyzed large-volume insurance claims data using SQL and SAS.

Before their role at L.E.K. Consulting, Lixia worked as a Statistician (part-time) at United Therapeutics from February 2011 to May 2015. In this role, they communicated with clients, designed statistical analysis plans, researched innovative methodologies, and developed SAS macros.

Lixia's early work experience includes a part-time role as a Business Analyst at GSK from September 2010 to December 2010, where they interviewed coordinators, designed surveys, and presented results to stakeholders. Lixia also served as a Teaching Assistant at North Carolina State University from January 2010 to May 2010.

Overall, Lixia Zhang has a strong background in data science, biostatistics, and market research, with experience in various industries including healthcare and pharmaceuticals.

Lixia Zhang pursued their education in a sequential manner, starting with a Bachelor of Science degree in Mathematics from Shanghai University, which they completed from 2005 to 2009. Lixia then continued their studies at North Carolina State University, where they obtained a Master's degree in Statistics from 2009 to 2011. Finally, Lixia enrolled in a Doctor of Philosophy (Ph.D.) program in Statistics at North Carolina State University, which they successfully completed from 2011 to 2016.